Journal
BIOMARKERS IN MEDICINE
Volume 11, Issue 1, Pages 11-18Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2016-0178
Keywords
bile CA199; bile survivin; cholangiocarcinoma; diagnosis; obstructive jaundice
Categories
Funding
- National Natural Sciences Foundation of China [81571367, 81401972]
- Shandong Provincial Natural Science Foundation of China [2015ZRE2760]
Ask authors/readers for more resources
Aim: To investigate whether bile survivin and carbohydrate antigen 199 (CA199) can be helpful in distinguishing cholangiocarcinoma (malignant obstructive jaundice) from benign obstructive jaundice. Methods: Receiver operating characteristic curve was used to evaluate the feasibility of bile survivin and CA199 in differentiating cholangiocarcinoma from benign obstructive jaundice. Results: The area under the curve for survivin and CA199 in bile and serum were 0.780 (p < 0.001), 0.6 (p = 0.084), 0.746 (p < 0.001) and 0.542 (p = 0.464), respectively. Combination of bile survivin and CA199 could improve the diagnostic capability. Conclusion: Bile survivin and CA199 are significantly increased in patients with cholangiocarcinoma and may be useful biomarkers in differentiating distinguishing cholangiocarcinoma from benign obstructive jaundice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available